Alafair Biosciences specializes in innovative medical devices designed to enhance postoperative recovery of soft tissues through the use of their patented platform technology. Their flagship product, VersaWrap®, is a biopolymer-based implant that provides a protective gliding surface for tendons and peripheral nerves during surgical procedures. This technology is particularly beneficial in preventing unwanted soft tissue tethering, which can occur as a natural response to surgical intervention. By utilizing non-collagenous, bioresorbable biomaterials, Alafair aims to improve patient outcomes and the overall surgical experience for healthcare providers, particularly in fields such as hand surgery, orthopedics, and reconstructive plastic surgery.

VersaWrap® has demonstrated effectiveness in various clinical applications, including tendon and nerve repairs, where it serves as a barrier to minimize postoperative scarring and adhesions. Case studies highlight its successful use in complex procedures, such as flexor tendon repairs and nerve decompression surgeries, where it has facilitated improved functional recovery and reduced complications. The technology's ability to allow for shorter nerve grafts during reconstructive surgeries further underscores its potential to enhance surgical outcomes and patient satisfaction. Overall, Alafair Biosciences is committed to advancing soft tissue protection and recovery through their innovative use of natural biopolymers in surgical applications.

United States

Alafair Biosciences is a privately-held, commercial-stage medical device company focused on the development of novel clinical products using its proprietary hydrogel technology. With a patent portfolio covering a broad range of clinical applications, Alafair is focused on building a robust product pipeline. Its products are distributed through a dispersed network of independent distributors across the United States. 

Alafair Biosciences

Company Details